Table 3.
Ficat stage at onset of treatment | Survival (number; %) | THA (number; %) |
---|---|---|
I (n = 16) | 15 (93.75%) | 1 (6.25%) |
II (n = 52) | 50 (96.16%) | 2 (3.84%) |
III (n = 10) | 7 (70%) | 3 (30%) |
Total (n = 78) | 72 (92.31%) | 6 (7.69%) |
Ficat stage at onset of treatment | Survival (number; %) | THA (number; %) |
---|---|---|
I (n = 16) | 15 (93.75%) | 1 (6.25%) |
II (n = 52) | 50 (96.16%) | 2 (3.84%) |
III (n = 10) | 7 (70%) | 3 (30%) |
Total (n = 78) | 72 (92.31%) | 6 (7.69%) |